Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01479478 · ClinicalTrials.gov registry record · NA
Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 251
- Enrollment target
NCT01479478: Completed NA study, sponsored by Stanford University.
NCT01479478 is a NA study that has completed, run by Stanford University. The registered enrollment target is 251 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01479478, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 251 participants
- Enrollment target
Study Summary
The investigators wish to determine if oral probiotic supplementation during the second half of pregnancy decreases maternal GBS recto-vaginal colonization at 35-37 weeks' gestational age, thereby decreasing need for maternal antibiotic administration at time of labor. The importance of this study is that it may offer a safer alternative to antibiotic treatment of group B Streptococcus (GBS) colonized pregnant women.
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Probiotic dietary supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2011-11 |
| Est. Completion | 2017-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01479478
The ClinicalTrials.gov registry entry for NCT01479478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01479478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01479478 about?
NCT01479478 is a clinical study titled "Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy". The investigators wish to determine if oral probiotic supplementation during the second half of pregnancy decreases maternal GBS recto-vaginal colonization at 35-37 weeks' gestational age, thereby decreasing need for maternal antibiotic administration at time of labor. The importance of this study i...
What is the current status of trial NCT01479478?
This trial is currently completed. It is a NA study. The enrollment target is 251 participants. The study started on 2011-11. Estimated completion is 2017-07-26.
What interventions are being tested in trial NCT01479478?
The interventions under investigation include: Placebo (DRUG), Probiotic dietary supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01479478?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.